Cash flows from operating activities: | |
Net income | 67.2M |
Adjustments to reconcile net income to net cash provided by operating activities: | |
Depreciation of property, plant and equipment | 25.5M |
Amortization of definite-lived intangible assets | |
Amortization of debt discount and debt issuance costs | 800K |
Deferred income taxes | |
Non-cash equity compensation | 8.8M |
Net non-cash LIFO charges | |
Non-cash unrealized losses on derivative positions | -16.9M |
Amortization of option premiums (received) paid, net | |
Non-cash impairment charges | |
Losses on disposition of property, plant and equipment | 200K |
Non-cash changes in net periodic benefit (income) costs relating to the VEBAs1 | |
Other non-cash changes in assets and liabilities | 1.1M |
Changes in operating assets and liabilities, net of effect of acquisition: | |
Trade and other receivables | -26.7M |
Receivable from affiliate | |
Inventories (excluding LIFO charges) | |
Prepaid expenses and other current assets | -900K |
Accounts payable | 800K |
Accrued liabilities | 27.9M |
Payable to affiliate | |
Long-term assets and liabilities, net | -15.8M |
Net cash provided by operating activities | |
Cash flows from investing activities: | |
Capital expenditures | -57.4M |
Purchase of available for sale securities | -201.1M |
Cash payment for acquisition of manufacturing facility and related assets (net of $4.9 of cash received in the acquisition) | |
Change in restricted cash | |
Net cash used in investing activities | -228.5M |
Cash flows from financing activities: | |
Proceeds from issuance of cash convertible senior notes | |
Cash paid for financing costs in connection with issuance of cash convertible senior notes | -6.8M |
Purchase of call option in connection with issuance of cash convertible senior notes | |
Proceeds from issuance of warrants | |
Repayment of promissory note | |
Cash paid for financing costs in connection with the revolving credit facility | |
Retirement of common stock | |
Repurchase of common stock | -13.6M |
Cash dividend paid to stockholders | -24.4M |
Net cash (used in) provided by financing activities | 122.3M |
Net (decrease) increase in cash and cash equivalents during the period | 400K |
Cash and cash equivalents at beginning of period | 72.5M |
Cash and cash equivalents at end of period | 72.9M |